United States · Venture startup
6 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$62Mraised across 6 rounds since 2006, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $1.0M sold, first sale May 2013
Reported by pharmalive.comSEC filing: $25M sold, first sale Feb 2011
No investor was named in the report.
Reported by sec.govSEC filing: $5.0M sold, first sale Mar 2010
From a historical funding record
No investor was named in the report.
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Bay City Capital
Advent Venture Partners
Gilde Healthcare
Aberdare Ventures
MPM Capital
Roche Venture FundGeneChemFrom historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
Conatus Pharmaceuticals's investors include Bay City Capital, Advent Venture Partners, Gilde Healthcare, Aberdare Ventures and MPM Capital, and 2 more on record.
Conatus Pharmaceuticals has raised $62M across 6 rounds since 2006.
Conatus Pharmaceuticals's most recent round was a Venture of $1.0M in Jun 2013.
Conatus Pharmaceuticals's largest round on record is $22M (Series A), in May 2007.
Conatus Pharmaceuticals's first round on record, in May 2007, was backed by Bay City Capital, Advent Venture Partners and Gilde Healthcare and 1 others.
Conatus Pharmaceuticals's latest named round is a Venture, in Jun 2013.
Conatus Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·